Sep 24, 2021

Monoclonal antibody treatments help with COVID-19, but not without a cost

Rows of beds and their letter designations are seen in a tent used for monoclonal antibody treatment of COVID-19 patients outside of St. Claire Regional Medical Center on September 16, 2021 in Morehead, Kentucky. Jon Cherry/Getty Images

Also today: In China, property giant Evergrande is about $300 billion in debt, and the deadline to address that debt has come and gone. Is it possible that a bailout could be in the works? There's been plenty of regulation in store for food delivery apps focused on worker protections, but there are questions about how the app companies might change under this climate.

Segments From this episode

Will Evergrande get rescued?

The property giant is $300 billion in debt, and it’s not clear how the company is going to handle it.

Listen Now

The team

David Brancaccio Host

Victoria Craig Host, BBC

Stephen Ryan Senior Producer, BBC

Jonathan Frewin Producer, BBC

Daniel Shin Producer

Jay Siebold Technical Director

Meredith Garretson Morbey Senior Producer

Erika Soderstrom Producer

Rose Conlon Producer

Alex Schroeder Producer

Redmond Carolipio Digital Producer

Jesson Duller Media Producer

Latest Episodes From Our Shows

5:37 PM PDT